ストックスクリーナーアプリを入手
182.67
1.13%
2.04
アフターアワーズ：
182.67
Danaher Corp (DHR) 最新ニュース
Danaher Corp. Hits Day High with Strong 4.33% Intraday Surge - Markets Mojo
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Leica Biosystems and CellCarta Expand Collaborative Companion Diagnostic Development Model to Accelerate Commercialization Globally - PR Newswire
Is Danaher Stock Underperforming the S&P 500? - Yahoo Finance
Danaher Corp. May Be the Smartest Bet in Biotech Right Now - AOL.com
Danaher Corp. stock (US2358511028): valuation metrics in focus after Q1 guidance raise - AD HOC NEWS
A Look at Danaher Corp (DHR) After 4.3% Gain -- GF Value $236.05 vs Price $180.63 - GuruFocus
Danaher Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Danaher Corp Stock (DHR) Moved Up by 3.30% on May 28: A Full Analysis - TradingKey
Rainer Blair: Innovative Leader, Danaher Business System Champion, and President and Chief Executive Officer of Danaher Corporation - BBN Times
Danaher (DHR) Receives Buy Rating from Citi with $230 Price Targ - GuruFocus
DHR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Danaher (DHR) Downgraded by Citigroup -- Price Target Lowered to $95 - GuruFocus
RBC Capital Resumes Coverage of Danaher Corporation (DHR) - Insider Monkey
Danaher Corp. stock (US2358511028): dividend timeline and institutional interest in focus - AD HOC NEWS
Cytiva introduces next-gen Biacore 8 series SPR systems for drug discovery - BioSpectrum Asia
Masimo earnings in focus as Danaher deal nears close - Investing.com
Danaher (DHR) Is Up 5.3% After Q1 Beat, EPS Hike And Biotech MomentumWhat's Changed - Yahoo Finance
Danaher Raises $3 Billion in Record Private-Placement Bond Sale - Bloomberg.com
Danaher Targets Carbon Capture And AI CMC To Shape Long Term Growth - Yahoo Finance
Danaher stock (US2358511028): diagnostics spin?off and Q1 earnings reshape the portfolio - AD HOC NEWS
Danaher Corp. stock (US2358511028): earnings beat keeps focus on life sciences recovery - AD HOC NEWS
Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR) - Barchart.com
Eagle Capital Management Bet on Danaher (DHR) for Its Mid-Teens EPS Growth - Yahoo Finance
Tissue Diagnostics Market to Reach USD 9.33 Bn by 2031 Driven by Expanding Precision Oncology Applications and Rising Adoption of Digital Pathology, Says Mordor Intelligence - GlobeNewswire Inc.
Danaher stock (US2358511028): spin-off, diagnostics focus and what the latest numbers reveal - AD HOC NEWS
Strength in Danaher's Biotechnology Unit Seems Firm: More Upside Ahead? - The Globe and Mail
Pall to Address a Key Decarbonization Challenge with Additively Manufactured Filtration - Carroll County Mirror-Democrat
Why The Narrative Around Danaher (DHR) Is Shifting With Bioprocess Recovery And Masimo Deal - Yahoo Finance
Danaher Corp. stock (US2358511028): insider awards highlight leadership confidence after guidance li - AD HOC NEWS
Danaher (NYSE: DHR) director Linda Filler receives stock and option grants - Stock Titan
Danaher (NYSE: DHR) SVP uses 281 shares for tax withholding, retains 8,291 - Stock Titan
[Form 4] DANAHER CORP /DE/ Insider Trading Activity - Stock Titan
Alan G. Spoon (DHR) awarded RSUs and stock options in new Danaher Form 4 - Stock Titan
Danaher (NYSE: DHR) director awarded RSUs and long-dated stock options - Stock Titan
Danaher (NYSE: DHR) director Teri List granted RSUs and stock options as board compensation - Stock Titan
Danaher (NYSE: DHR) awards director Zerhouni RSUs and stock options - Stock Titan
Danaher (NYSE: DHR) director granted RSUs and options in new award - Stock Titan
Danaher (DHR) director Charles Lamanna awarded RSUs and 1,699-share option - Stock Titan
Danaher shares climb as analysts turn more constructive after Q1 guidance lift - Quiver Quantitative
Danaher Corp. stock (US2358511028): restructuring after spin-off, new focus on life sciences - AD HOC NEWS
Northwestern Mutual Wealth Management Co. Acquires 186,584 Shares of Danaher Corporation $DHR - MarketBeat
Life Science Instrumentation Market Forecast Report 2025-2031: Expanding Activities in Genomics, Proteomics, and Drug Discovery with Thermo Fisher Scientific, Danaher, Agilent, and Shimadzu Leading - Yahoo Finance
Danaher stock (US2358511028): Q1 figures, dividend and analyst views in focus - AD HOC NEWS
Danaher stock (US2358511028): earnings momentum and dividend in focus for US investors - AD HOC NEWS
Masimo Corp stock (US5747951003): earnings, Danaher deal and what’s next for the medical-tech spec - AD HOC NEWS
Solid Q1 and Guidance Underlines Why Danaher Corporation (DHR) is one of Steve Cohen’s Large-Cap Stock Picks - Insider Monkey
Danaher Masimo Deal Shifts Growth Outlook And Investor Focus - Yahoo Finance
DoorDash Inc stock (US2358511028): Q1 2026 profit beat keeps growth story in focus - AD HOC NEWS
Danaher Corporation Trade Ideas — AQUISEU:DAPD - TradingView
Danaher Valuation Reset Highlights Recurring Revenues And Lean Operating Framework - Yahoo Finance
Danaher Seen on Path to Growth Reacceleration on Bioprocess Recovery, RBC Says - marketscreener.com
DHR Reinstated by RBC Capital -- Price Target Set at $200 - GuruFocus
Danaher Stock: Analyst Estimates & Ratings - Barchart
Danaher stock (US2358511028): spin-offs reshape the medtech group after latest quarterly numbers - AD HOC NEWS
Danaher (DHR) Receives Outperform Rating from RBC Capital with $200 Price Target - GuruFocus
1.09%
0.79%
大文字化:
|
ボリューム (24 時間):